Advertisement
Home Tags Immunotherapy

Tag: Immunotherapy

Tecentriq (atezolizumab) has been approved by the U.S. Food and Drug Administration to treat adults with extensive-stage small cell lung cancer.

FDA OKs Tecentriq for Extensive-Stage Small Cell Lung Cancer

0
Drug now approved as first-line treatment to be used in combination with carboplatin and etoposide
The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer.

FDA Approves First Immunotherapy Drug for Breast Cancer

0
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Egg-allergic children who undergo egg oral immunotherapy and achieve sustained unresponsiveness eat more egg and have fewer symptoms five years later

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

0
All children with sustained unresponsiveness ingested concentrated and baked egg
Most individuals who complete peanut immunotherapy trials continue peanut consumption with few reports of reactions

AAAAI: Small Amounts of Dietary Peanuts Beneficial After Immunotherapy

0
Regular peanut consumption after OIT, SLIT for peanut allergy provides continued protection
Egg-allergic children who undergo egg oral immunotherapy and achieve sustained unresponsiveness eat more egg and have fewer symptoms five years later

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

0
All children with sustained unresponsiveness ingested concentrated and baked egg
Medical science has made tremendous advances in personalized medicine. However

Many Americans Unaware of Promise of Personalized Medicine

0
41 percent are not at all familiar with personalized medicine; only 5 percent say they are very familiar
For heavily pretreated patients with relapsed/refractory non-Hodgkin lymphoma or Hodgkin lymphoma

ASH: High Response to Tx After Checkpoint Blockade in NHL, HL

0
Immunotherapy boosts later therapy for relapsed, refractory non-Hodgkin, Hodgkin lymphoma
Adverse events for immune checkpoint inhibitors used to treat non-small cell lung cancer may be more common in real-world settings than reported in the clinical trials that led to U.S. Food and Drug Administration approvals

Immunotherapy Side Effects May Be More Common Than Thought

0
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
Patients with peanut allergy who received oral immunotherapy

ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy

0
More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms
For patients with metastatic triple-negative breast cancer

Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer

0
Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease